What does the evidence say about Resveratrol Cognitive Performance Randomized Trial?

The current Migaku evidence database contains 1 reusable source document for Resveratrol Cognitive Performance Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Dietary patterns have emerged as modifiable risk factors that may influence disease onset and progression. [Fekete M (2025); evidence level 4] - The Mediterranean diet (MedDiet), rich in fruits, vegetables, whole grains, legumes, fish, and extra virgin olive oil, has been consistently associated with better cognitive outcomes and reduced risk of neurodegeneration. [Fekete M (2025); evidence level 4] - Aim: This narrative review summarizes current evidence on the role of the MedDiet in slowing the progression of neurodegenerative diseases, with a particular focus on polyphenols such as resveratrol and oleuropein as key bioactive mediators. [Fekete M (2025); evidence level 4] - Background: Neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, are among the leading causes of disability and mortality worldwide. [Fekete M (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.